The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this.
Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly
Dr Anthony Yanni, senior vice president and global head of patient centricity at Astellas Pharma, returns to Health Innovators to continue his conversation with Healthware’s chief content o
